Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a MRI study of MLN1202 in relapsing-remitting multiple sclerosis
2004-002567-24Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Feb 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of plozalizumab in multiple sclerosis (MS), sponsored by Millennium Pharmaceuticals. Primary endpoint: Safety. Started Feb 2005; status: completed.
02
Drugs
plozalizumab
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2004-002567-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002567-24.